by Vora Corporate Finance | Aug 19, 2025 | Insights
The US-China trade war has entered a new and precarious phase. What began as a series of tariffs and retaliatory measures has escalated into a systemic confrontation reshaping global trade dynamics. In early April 2025, President Trump imposed sweeping tariffs of up...
by Vora Corporate Finance | Apr 16, 2025 | Insights
There were No main board IPOs in March 2025 against 04 main board IPOs in February 2025. There were 07 SME IPOs in March 2025 as against 06 SME IPOs in February 2025. After heightened activity in 2024, there has been a slowdown in new listings, with no main-board...
by Vora Corporate Finance | Apr 16, 2025 | Insights
The BSE Sensex closed at 77,414.92 gaining by 5.76% and the Nifty 50 closed at 23,519.35 gaining by 6.30% in March 2025, pausing after a six-session rally that erased their 2025 losses, as uncertainty over U.S. reciprocal import tariffs kept investors cautious....
by Vora Corporate Finance | Mar 27, 2025 | Insights, Merger & Acquisitions
Transaction: Fortis Healthcare Limited is set to acquire the 228-bed Shrimann Superspeciality Hospital in Jalandhar for approximately $53m (INR 462 crores) through a slump sale. The acquisition includes the entire business operations, hospital building, land, and an...
by Vora Corporate Finance | Mar 27, 2025 | Insights
There were 04 main board IPOs in February 2025 of Quality Power Electrical Equipments Limited, Hexaware Technologies Limited, AJAX Engineering Limited, and Dr. Agarwal’s Health Care Limited against 06 main board IPOs in January 2025. There were 06 SME IPOs in...
